Skip to main navigation Skip to search Skip to main content

Pilot Evaluation of Endothelin-1 and TG/HDL-C Ratio for Early Cardiovascular Risk Stratification in Adiposity-Based and Cardiovascular-Kidney-Metabolic Syndromes

  • Aldian Arie Pratama*
  • , Agustin Iskandar
  • , Singgih Pudjo Wahono
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Adiposity-related chronic diseases and cardiovascular-kidney-metabolic (CKM) syndrome significantly contribute to the burden of non-communicable diseases (NCDs), especially in low-and middle-income countries (LMICs), where early risk stratification is still inadequate. This study evaluated the efficacy of endothelin-1 (ET-1) and the triglyceride-to-high-density lipoprotein cholesterol (TG/HDL-C) ratio as early, cost-efficient biomarkers for cardiovascular risk assessment in persons with adiposity-based chronic disease (ABCD) and early-stage CKM syndrome.

Original languageEnglish
Pages (from-to)51-60
Number of pages10
JournalCor et Vasa
Volume68
Issue number1
DOIs
Publication statusPublished - 2026

Keywords

  • Adiposity-based chronic disease
  • Atherogenic index of plasma
  • Cardiovascular risk assessment
  • Cardiovascular-kidney-metabolic syndrome
  • Endothelin-1
  • Triglyceride-to-HDL cholesterol ratio

Fingerprint

Dive into the research topics of 'Pilot Evaluation of Endothelin-1 and TG/HDL-C Ratio for Early Cardiovascular Risk Stratification in Adiposity-Based and Cardiovascular-Kidney-Metabolic Syndromes'. Together they form a unique fingerprint.

Cite this